`
`
`
`
`
`
`
`
`
`
`
`
`Filed: October 7, 2019
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`MYLAN PHARMACEUTICALS INC.,
`SAWAI USA, INC., AND
`SAWAI PHARMACEUTICAL CO., LTD.
`Petitioners,
`
`v.
`
`BIOGEN MA, INC.
`Patent Owner.
`
`
`
`
`Case No. IPR2018-014031
`Patent No. 8,399,514
`
`
`
`
`REQUEST FOR ORAL ARGUMENT
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1 Case IPR2019-00789 has been joined with this proceeding.
`
`
`
`
`
`
`
`Pursuant to the Board’s Scheduling Order (Paper 13), Petitioner Mylan
`
`Pharmaceuticals Inc. respectfully requests oral argument, currently scheduled for
`
`November 13, 2019.
`
`Pursuant to 37 C.F.R. § 42.70(a), Petitioner intends to argue the following
`
`issues:
`
`1. Any issues addressed by Petitioners, including in the Petition for Inter
`
`Partes Review and Reply in any of the proceedings, including whether any claim
`
`of U.S. Patent No. 8,399,514 is patentable.
`
`2. Any issues properly raised by Patent Owner, including in Patent Owner’s
`
`Response and Sur-Reply.
`
`3. Rebuttal to issues raised by Patent Owner.
`
`4. Any motions to exclude evidence by Petitioner.
`
`5. Any motions to exclude evidence by Patent Owner.
`
`6. Any issues properly raised in Patent Owner’s Request for Oral Argument.
`
`Petitioner requests that each side have 45 minutes for oral argument.
`
`Petitioner also requests the ability to use audio/visual equipment to display
`
`demonstrative exhibits, including the use of a projector and screen for a
`
`PowerPoint presentation.
`
`2
`
`
`
`
`
`
`
`Petitioner also requests that ten spaces be reserved at the oral hearing to
`
`accommodate counsel and corporate representatives. Petitioner also requests that
`
`two attorneys be allowed to use computers at the hearing.
`
`Dated: October 7, 2019
`
`
`
`
`
`/s/ Emily J. Greb
`Emily J. Greb
`Reg. No. 68,244
`Perkins Coie LLP
`33 East Main Street, Suite 201
`Madison, WI 53703
`Telephone: (608) 663-7494
`E-mail: egreb@perkinscoie.com
`
`3
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that the foregoing REQUEST FOR ORAL
`
`ARGUMENT was severed electronically via email as follows:
`
`
`
`
`
`
`
`
`
`
`
`
`
`Barbara C. McCurdy
`Mark J. Feldstein
`Erin M. Sommers
`Pier D. DeRoo
`Cora R. Holt
`Finnegan, Henderson, Farabow,
`Garrett & Dunner, LLP
`barbara.mccurdy@finnegan.com
`mark.feldstein@finnegan.com
`erin.sommers@finnegan.com
`pier.deroo@finnegan.com
`cora.holt@finnegan.com
`
`Counsel for Patent Owner
`
`Petitioner for Sawai USA, Inc., Sawai Pharmaceutical Co., Ltd:
`Brian Sodikoff
`Christopher B. Ferenc
`
`Katten Muchin Rosenman LLP
`
`brian.sodikoff@kattenlaw.com
`
`christopher.ferenc@kattenlaw.com
`
`/s/Emily J. Greb
`Dated: October 7, 2019
`Emily J. Greb
`Reg. No. 68,244
`
`
`
`
`
`Counsel for Petitioner Mylan Pharmaceuticals Inc.
`
`
`
`